Heron shareholders approve share issuances exceeding 19.99% threshold

HERON THERAPEUTICS, INC. /DE/

On Oct 13, 2025, shareholders approved issuance of shares upon conversion of convertible notes due 2031 (89.6M for, 5.6M against).
Shareholders also approved issuance upon automatic conversion of Series A Convertible Preferred Stock (91.5M for, 3.7M against).
Both proposals passed to comply with Nasdaq Listing Rule 5635(d) for potential issuances exceeding 19.99% of outstanding common stock.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.